Cover Image
市場調查報告書

脊椎治療用生物來源產品的全球市場的預測 ∼2020年:各產品類型 (骨移植片、骨移植片替代物、多血小板血漿、BMAC)、手術區分、終端用戶、地區

Spine Biologics Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 345735
出版日期 內容資訊 英文 103 Pages
訂單完成後即時交付
價格
Back to Top
脊椎治療用生物來源產品的全球市場的預測 ∼2020年:各產品類型 (骨移植片、骨移植片替代物、多血小板血漿、BMAC)、手術區分、終端用戶、地區 Spine Biologics Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020
出版日期: 2015年11月24日 內容資訊: 英文 103 Pages
簡介

全球脊椎治療用生物來源產品的市場預計從2015年到2020年以4.4%的年複合成長率發展,2020年成長到24億美元的規模。老年人口的增加和最小侵入性手術的擴大等對該市場的成長有所貢獻。

本報告提供全球脊椎治療用生物來源產品的市場相關調查、產品定義和概要、市場促進因素&阻礙要素及市場機會分析、手術及各產品類型的主要趨勢與市場規模的變化與預測、地區及主要國家趨勢、競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 市場促進因素&阻礙要素

第5章 市場分析:手術各種類

  • 簡介
  • 頸椎前開椎間盤切除及融合術 (ACDF)
  • 後方腰椎椎間融合術 (PLIF)
  • 經椎間孔入路椎體間融合術 (TLIF)
  • 前側椎間融合術 (ALIF)
  • 側面途徑腰椎椎間融合術 (LLIF)
  • 其他

第6章 市場分析:各產品類型

  • 簡介
  • 骨移植片
    • 自體移植片
    • 異體移植片
  • 骨移植片替代物
    • 合成骨移植片
    • 去礦物質骨基質 (DBM)
    • 骨形成蛋白 (BMP)
  • 多血小板血漿 (PRP)
  • 骨髓穿刺濃縮 (BMAC) 療法

第7章 地區分析

  • 簡介
  • 北美
    • 市場分析:各國
    • 市場分析:各產品類型
    • 骨移植片替代市場:各產品類型
    • 市場分析:外科手術別
  • 歐洲
    • 市場分析:各國
    • 市場分析:各產品類型
    • 骨移植片替代市場:各產品類型
    • 市場分析:外科手術別
  • 亞太地區
    • 市場分析:各國
    • 市場分析:各產品類型
    • 骨移植片替代市場:各產品類型
    • 市場分析:外科手術別

第8章 競爭環境

  • 企業佔有率分析
  • 產品的投入
  • M&A
  • 合作、協定、擴張、聯盟
  • 認證、聯盟、重定位、授權

第9章 企業簡介

  • ZIMMER HOLDING, INC.
  • DEPUY SYNTHES
  • MEDTRONIC, INC.
  • NUVASIVE, INC.
  • STRYKER CORPORATION
  • ORTHOFIX INTERNATIONAL N.V.
  • K2M, INC.
  • EXACTECH, INC.
  • WRIGHT MEDICAL TECHNOLOGY, INC.
  • NUTECH
  • ARTHREX, INC.
  • X-SPINE SYSTEMS, INC. (BACTERIN INTERNATIONAL HOLDINGS, INC.)
  • DR PRP USA LLC
    • 概要
    • 財務趨勢
    • 產品與服務
    • 策略
    • 發展趨勢等

第10章 附錄

圖表

目錄
Product Code: MD 3914

Spinal biologics are devices that are used extensively for bone fusion surgery, spinal cord injury, and degenerative disk disease. The treatment may include the use of allografts, autografts, mesenchymal stem cells, demineralized bone matrix, bone morphogenetic protein, and ceramics. These materials assist the body's natural healing processes and are used to heal spine diseased or degenerated discs. The effects is perceived through increased cellular activity, growth, and differentiation. For example, in case of materials such as pedicle rods and screws used in spine fusion cases to provide spinal stability and fusion healing. However, since metals are inert in nature, they do not stimulate or activate cellular growth or alter cellular functions such as natural healing. Biologic materials are increasingly being preferred by surgeons performing spinal fusion surgeries as their use facilitates the fusion process due to their stimulant effect on spine fusion. The global spine biologics market constituted 33.5% of the global spinal implants and spinal devices market in 2014.

Spine biologics find application in spine surgery as lieu allografts as well as a support for bones in and around the spinal region. They can also be used cure the spinal injuries or trauma or degenerated discs. Currently, bone morphogenetic proteins (BMP's) are biologic materials that are predominantly used in spinal surgery. Bone graft substitutes claim for around 85% share of the total spine biologics market.

The global spine biologics market size is expected to reach $2.4 billion by 2020, at a CAGR of 4.4% during the forecast period of 2015 to 2020. Growing aging population and rise in the application of minimally invasive surgeries are the major factors influencing the growth of this market.

The global spine biologics market report studies the major regions, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW).

In 2014, North America estimated accounted for the largest share of the global spine biologics market. As growth of healthcare industry is affected by the healthcare expenditure, increased investments in life sciences are expected to fuel the growth of the global spine biologics market in this region. The European spine biologics market is the second-largest. APAC is estimated to be the fastest growing market for spine biologics during the forecast period.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are Medtronic Inc. (U.S.), DePuy Synthes Companies (U.S.), Zimmer Holding Inc. (U.S.), Nuvasive Inc. (U.S.), Stryker Corporation (U.S.), Orthofix International N.V. (U.S.), K2M Inc. (U.S.), Exactech Inc. (U.S.), and Wright Medical Technology Inc. (U.S.), among others.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities for the global spine biologics market.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.

The report provides insights on the following pointers:

  • Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global spine biologics market are provided.
  • Market Development: Comprehensive information about lucrative emerging markets is provided. The report also analyzes the markets for spine biologics across various regions, exploit new distribution channels, new clientele base, and different pricing policies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the Global spine biologics market is provided. Detailed description regarding the related and unrelated diversification pertaining to this market is also provided.
  • Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players forecasted till 2020 is provided.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET SEGMENTATION & COVERAGE
  • 1.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. INTEGRATED ECOSYSTEM OF SPINE BIOLOGICS MARKET
  • 2.2. ARRIVING AT THE SPINE BIOLOGICS MARKET SIZE
    • 2.2.1. TOP-DOWN APPROACH
    • 2.2.2. BOTTOM-UP APPROACH
    • 2.2.3. MACRO INDICATOR-BASED APPROACH
  • 2.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. MARKET DRIVERS AND INHIBITORS

5. SPINE BIOLOGICS MARKET, BY SURGERY TYPE

  • 5.1. INTRODUCTION
  • 5.2. ANTERIOR CERVICAL DISCECTOMY AND FUSION (ACDF)
  • 5.3. POSTERIOR LUMBAR INTERBODY FUSION (PLIF)
  • 5.4. TRANSFORAMINAL LUMBAR INTERBODY FUSION (TLIF)
  • 5.5. ANTERIOR LUMBAR INTERBODY FUSION (ALIF)
  • 5.6. LATERAL LUMBAR INTERBODY FUSION (LLIF)
  • 5.7. OTHERS

6. SPINE BIOLOGICS MARKET BY PRODUCT TYPE

  • 6.1. INTRODUCTION
  • 6.2. BONE GRAFT
    • 6.2.1. AUTOGRAFT
    • 6.2.2. ALLOGRAFT
  • 6.3. BONE GRAFT SUBSTITUTES
    • 6.3.1. SYNTHETIC BONE GRAFTS
    • 6.3.2. DEMINERALIZED BONE MATRIX (DBM)
    • 6.3.3. BONE MORPHOGENETIC PROTEINS (BMP)
  • 6.4. PLATELET RICH PLASMA (PRP)
  • 6.5. BONE MARROW ASPIRATE (BMAC) THERAPY

7. SPINE BIOLOGICS MARKET, BY GEOGRAPHY

  • 7.1. INTRODUCTION
  • 7.2. NORTH AMERICA
    • 7.2.1. SPINE BIOLOGICS MARKET, BY COUNTRY
    • 7.2.2. SPINE BIOLOGICS MARKET, BY PRODUCT TYPE
    • 7.2.3. BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT TYPE
    • 7.2.4. SPINE BIOLOGICS MARKET, BY SURGERY TYPE
  • 7.3. EUROPE
    • 7.3.1. SPINE BIOLOGICS MARKET, BY COUNTRY
    • 7.3.2. SPINE BIOLOGICS MARKET, BY PRODUCT TYPE
    • 7.3.3. BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT TYPE
    • 7.3.4. SPINE BIOLOGICS MARKET, BY SURGERY TYPE
  • 7.4. ASIA PACIFIC
    • 7.4.1. SPINE BIOLOGICS MARKET, BY COUNTRY
    • 7.4.2. SPINE BIOLOGICS MARKET, BY PRODUCT TYPE
    • 7.4.3. BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT TYPE
    • 7.4.4. SPINE BIOLOGICS MARKET, BY SURGERY TYPE

8. COMPETITIVE LANDSCAPE

  • 8.1. COMPANY SHARE ANALYSIS
  • 8.2. PRODUCT LAUNCHES
  • 8.3. MERGERS AND ACQUISITIONS
  • 8.4. COLLABORATIONS, JOINT AGREEMENTS & EXPANSIONS, PARTNERSHIPS
  • 8.5. APPROVALS, ALLIANCES, RELOCATION & LICENSING

9. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, and Developments)*

  • 9.1. ZIMMER HOLDING, INC.
  • 9.2. DEPUY SYNTHES
  • 9.3. MEDTRONIC, INC. (U.S.)
  • 9.4. NUVASIVE, INC.
  • 9.5. STRYKER CORPORATION
  • 9.6. ORTHOFIX INTERNATIONAL N.V.
  • 9.7. K2M, INC.
  • 9.8. EXACTECH, INC.
  • 9.9. WRIGHT MEDICAL TECHNOLOGY, INC.
  • 9.10. NUTECH
  • 9.11. ARTHREX, INC.
  • 9.12. X-SPINE SYSTEMS, INC. (BACTERIN INTERNATIONAL HOLDINGS, INC.)
  • 9.13. DR PRP USA LLC

*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company

10. APPENDIX

  • 10.1. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 10.2. CUSTOMIZATION OPTIONS
    • 10.2.1. PRODUCT ANALYSIS
    • 10.2.2. SPINE SURGEONS/ DOCTORS PERCEPTION ANALYSIS
    • 10.2.3. REGULATORY FRAMEWORK
    • 10.2.4. COMPETITIVE INTELLIGENCE
  • 10.3. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: SPINE BIOLOGICS MARKET: HEALTHCARE EXPENDITURE, BY GEOGRAPHY, 2014 (USD MILLION)
  • TABLE 2: SPINE BIOLOGICS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 3: SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2013-2020 (USD MILLION)
  • TABLE 4: SPINE BIOLOGICS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 5: SPINE BIOLOGICS MARKET: DRIVERS AND INHIBITORS
  • TABLE 6: SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2013-2020 (USD MILLION)
  • TABLE 7: SPINE BIOLOGICS MARKET IN ANTERIOR CERVICAL DISCECTOMY AND FUSION (ACDF) SURGERY, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 8: SPINE BIOLOGICS MARKET IN ANTERIOR CERVICAL DISCECTOMY AND FUSION (ACDF) SURGERY, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 9: SPINE BIOLOGICS MARKET IN TRANSFORAMINAL LUMBAR INTERBODY FUSION (TLIF) SURGERY, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 10: SPINE BIOLOGICS MARKET IN TRANSFORAMINAL LUMBAR INTERBODY FUSION (TLIF) SURGERY, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 11: SPINE BIOLOGICS MARKET IN ANTERIOR LUMBAR INTERBODY FUSION (ALIF) SURGERY, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 12: SPINE BIOLOGICS MARKET IN ANTERIOR LUMBAR INTERBODY FUSION (ALIF) SURGERY, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 13: SPINE BIOLOGICS MARKET IN LATERAL LUMBAR INTERBODY FUSION (LLIF) SURGERY, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 14: SPINE BIOLOGICS MARKET IN LATERAL LUMBAR INTERBODY FUSION (LLIF) SURGERY, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 15: SPINE BIOLOGICS MARKET VALUE BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 16: BONE GRAFTS MARKET VALUE BY SURGERY TYPE, 2013-2020 (USD MILLION)
  • TABLE 17: BONE GRAFTS MARKET VALUE BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 18: BONE GRAFT SUBSTITUTES MARKET VALUE BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 19: SYNTHETIC BONE GRAFTS MARKET VALUE BY SURGERY TYPE, 2013-2020 (USD MILLION)
  • TABLE 20: SYNTHETIC BONE GRAFTS MARKET VALUE BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 21: DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE BY SURGERY TYPE, 2013-2020 (USD MILLION)
  • TABLE 22: DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 23: BONE MORPHOGENETIC PROTEIN (BMP) MARKET VALUE BY SURGERY TYPE, 2013-2020 (USD MILLION)
  • TABLE 24: BONE MORPHOGENETIC PROTEIN (BMP) MARKET VALUE BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 25: PLATELET RICH PLASMA (PRP) MARKET VALUE BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 26: BONE MARROW ASPIRATE CONCENTRATE (BMAC) THERAPY MARKET VALUE BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 27: SPINE BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2013 - 2020 (USD MILLION)
  • TABLE 28: NORTH AMERICA: SPINE BIOLOGICS MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: NORTH AMERICA: SPINE BIOLOGICS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 30: NORTH AMERICA: BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 31: NORTH AMERICA: SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2013-2020 (USD MILLION)
  • TABLE 32: EUROPE: SPINE BIOLOGICS MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: EUROPE: SPINE BIOLOGICS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 34: EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 35: EUROPE: SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2013-2020 (USD MILLION)
  • TABLE 36: ASIA PACIFIC: SPINE BIOLOGICS MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 37: ASIA PACIFIC: SPINE BIOLOGICS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: ASIA PACIFIC: BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 39: ASIA PACIFIC: SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2013-2020 (USD MILLION)
  • TABLE 40: SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2014
  • TABLE 41: PRODUCT LAUNCHES
  • TABLE 42: MERGERS AND ACQUISITIONS
  • TABLE 43: COLLABORATIONS, JOINT AGREEMENTS & EXPANSIONS
  • TABLE 44: APPROVALS, ALLIANCES, RELOCATION & LICENSING
  • TABLE 45: ZIMMER HOLDING, INC.: REVENUE, BY BUSINESS SEGMENT, 2009-2014 (USD MILLION)
  • TABLE 46: JOHNSON & JOHNSON LTD.: REVENUE, BY BUSINESS SEGMENT, 2011-2014 (USD MILLION)
  • TABLE 47: MEDTRONIC, INC. : REVENUE, BY BUSINESS SEGMENT, 2009-2013 (USD MILLION)
  • TABLE 48: NUVASIVE, INC.: REVENUE, BY PRODUCT TYPE, 2010-2014 (USD MILLION)
  • TABLE 49: STRYKER CORPORATION.: REVENUE, BY BUSINESS SEGMENT, 2010-2014 (USD MILLION)
  • TABLE 50: ORTHOFIX HOLDINGS, INC.: REVENUE, BY BUSINESS SEGMENT, 2012-2014 (USD MILLION)
  • TABLE 51: K2M INC.: REVENUE, 2011-2014 (USD MILLION)
  • TABLE 52: EXACTECH, INC.: REVENUE, BY BUSINESS SEGMENT, 2010-2014 (USD MILLION)
  • TABLE 53: EXACTECH, INC.: KEY FINANCIALS, BY GEOGRAPHY, 2010-2014 (USD MILLION)
  • TABLE 54: WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE, BY BUSINESS SEGMENT, 2011-2013 (USD MILLION)
  • TABLE 55: WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE, BY GEOGRAPHY, 2011-2013 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: SPINE BIOLOGICS MARKET: SEGMENTATION & COVERAGE
  • FIGURE 2: SPINE BIOLOGICS MARKET: INTEGRATED ECOSYSTEM
  • FIGURE 3: RESEARCH METHODOLOGY
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: MACRO INDICATOR-BASED APPROACH (2014)
  • FIGURE 7: SPINE BIOLOGICS MARKET SNAPSHOT
  • FIGURE 8: SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2014 & 2020 (USD MILLION)
  • FIGURE 9: SPINE BIOLOGICS MARKET IN ANTERIOR CERVICAL DISCECTOMY AND FUSION (ACDF) SURGERY, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 10: SPINE BIOLOGICS MARKET IN ANTERIOR CERVICAL DISCECTOMY AND FUSION (ACDF) SURGERY, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 11: SPINE BIOLOGICS MARKET IN TRANSFORAMINAL LUMBAR INTERBODY FUSION (TLIF) SURGERY, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 12: SPINE BIOLOGICS MARKET IN TRANSFORAMINAL LUMBAR INTERBODY FUSION (TLIF) SURGERY, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 13: SPINE BIOLOGICS MARKET IN ANTERIOR LUMBAR INTERBODY FUSION (ALIF) SURGERY, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 14: SPINE BIOLOGICS MARKET IN ANTERIOR LUMBAR INTERBODY FUSION (ALIF) SURGERY, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 15: SPINE BIOLOGICS MARKET IN LATERAL LUMBAR INTERBODY FUSION (LLIF) SURGERY, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 16: SPINE BIOLOGICS MARKET IN LATERAL LUMBAR INTERBODY FUSION (LLIF) SURGERY, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 17: SPINE BIOLOGICS MARKET VALUE, BY PRODUCT TYPE, 2014 & 2020 (USD MILLION)
  • FIGURE 18: BONE GRAFTS MARKET VALUE, BY SURGERY TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 19: SPINE GRAFTS MARKET VALUE, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 20: BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT TYPE, 2014 & 2020 (USD MILLION)
  • FIGURE 21: SYNTHETIC BONE GRAFTS MARKET VALUE, BY SURGERY TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 22: SYNTHETIC BONE GRAFTS MARKET VALUE, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 23: DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY SURGERY TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 24: DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 25: BONE MORPHOGENETIC PROTEIN (BMP) MARKET VALUE, BY SURGERY TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 26: BONE MORPHOGENETIC PROTEIN (BMP) MARKET VALUE, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 27: PLATELET RICH PLASMA (PRP) MARKET VALUE, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 28: BONE MARROW ASPIRATE CONCENTRATE (BMAC) THERAPY MARKET VALUE, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 29: SPINE BIOLOGICS MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2014 - 2020 (USD MILLION)
  • FIGURE 30: NORTH AMERICA: SPINE BIOLOGICS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 31: NORTH AMERICA: SPINE BIOLOGICS MARKET, BY COUNTRY, 2015 & 2020 (USD MILLION)
  • FIGURE 32: NORTH AMERICA: SPINE BIOLOGICS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 33: NORTH AMERICA: BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 34: NORTH AMERICA: SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 35: EUROPE: SPINE BIOLOGICS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 36: EUROPE: SPINE BIOLOGICS MARKET, BY COUNTRY, 2015 & 2020 (USD MILLION)
  • FIGURE 37: EUROPE: SPINE BIOLOGICS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 38: EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 39: EUROPE: SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 40: ASIA PACIFIC: SPINE BIOLOGICS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 41: ASIA PACIFIC: SPINE BIOLOGICS MARKET, BY COUNTRY, 2015 & 2020 (USD MILLION)
  • FIGURE 42: ASIA PACIFIC: SPINE BIOLOGICS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 43: ASIA PACIFIC: BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 44: ASIA PACIFIC: SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 45: SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 46: ZIMMER HOLDING, INC.: REVENUE MIX, 2014 (%)
  • FIGURE 47: JOHNSON & JOHNSON LTD.: BUSINESS REVENUE MIX, 2014 (%)
  • FIGURE 48: MEDTRONIC, INC.: REVENUE MIX, 2013 (%)
  • FIGURE 49: NUVASIVE INC.: REVENUE MIX, 2014 (%)
  • FIGURE 50: STRYKER CORPORATION: REVENUE MIX, 2014 (%)
  • FIGURE 51: ORTHOFIX INTERNATIONAL N.V.: BUSINESS REVENUE MIX, 2014 (%)
  • FIGURE 52: K2M, INC.: GEOGRAPHIC REVENUE MIX, 2014 (%)
  • FIGURE 53: EXACTECH, INC.: REVENUE MIX, 2014 (%)
  • FIGURE 54: WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE MIX, 2014 (%)
Back to Top